Source: Annual Congress 2003 - Asthma and rhinitis
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. M. Wilson, K. Parameswaran, P. M. O‘Byrne (Hamilton, Canada). Leukotriene receptor antagonists for allergic rhino-sinusitis: a systematic review and meta-analysis. Eur Respir J 2003; 22: Suppl. 45, 751

Member's Comments

No comment yet.

Related content which might interest you: Adverse drug reactions of leukotriene receptor antagonists in children with asthma: a systematic review Source: Virtual Congress 2021 – Paediatric allergic asthma: novel therapeutics and monitoring approaches Year: 2021 The effects of nebulised beta-2 agonists on clinical observations in asthma exacerbations: a systematic review Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 A prospective study of asthma and rhinitis interrelationships with reference to the incidence of eczema and the use of leukotreine receptor antagonists Source: Eur Respir J 2001; 18: Suppl. 33, 200s Year: 2001 Tiotropium provides greater improvements in FEV1 than leukotriene receptor antagonists as add-on to ICS in adults with asthma: a systematic review Source: International Congress 2018 – New developments in the treatment of asthma Year: 2018 Factors influencing the relative effect of leukotriene receptor antagonists (LTRA) and inhaled corticosteroids (ICS) as monotherapy in persistent asthma: A systematic review Source: Annual Congress 2011 - Asthma management and response Year: 2011 Clinical efficacy of leukotriene antagonist in patients with asthma and allergic rhinitis Source: Eur Respir J 2005; 26: Suppl. 49, 254s Year: 2005 Deprescribing montelukast in children with asthma: a systematic review Source: Virtual Congress 2021 – Paediatric allergic asthma: novel therapeutics and monitoring approaches Year: 2021 Roles of PI3k pan-inhibitors and PI3k-d inhibitors in allergic lung inflammation: systematic review and a meta-analysis Source: Virtual Congress 2020 – Management of allergy, asthma and COPD Year: 2020 The CysLT1 receptor antagonist montelukast blocks bronchoconstriction induced by inhaled leukotriene E4 in subjects with asthma Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 QOL questionnaire results in correlation with effects of leukotriene receptor antagonist in asthma and allergic rhinitis Source: Annual Congress 2008 - Exercise-induced asthma, acute severe asthma and allergic rhinitis in children Year: 2008 Leukotriene C4 synthase polymorphism does not associate with clinical response to leukotriene receptor antagonists in persistent asthma Source: Eur Respir J 2002; 20: Suppl. 38, 303s Year: 2002 Pharmacological treatment of asthma today Source: Eur Respir J 2001; 18: 34S-40S Year: 2001 Muscarinic receptors, leukotriene B4 production and neutrophilic inflammation in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 20s Year: 2004 Inhaled corticosteroids in asthma and longitudinal change in lung function: a systematic review and meta-analysis Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies Year: 2019 Antagonists for Chemoattractant receptor-homologous molecule expressed on Th2 cells in asthma: a meta-analysis and systematic review Source: International Congress 2018 – Asthma management Year: 2018 The CysLT1 receptor antagonist montelukast inhibits mast cell activation induced by inhaled leukotriene E4 in subjects with asthma Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016 Omalizumab reduces asthma exacerbations and oral corticosteroid use in patients with severe allergic asthma: a systematic review of observational studies Source: International Congress 2019 – Clinical studies of asthma treatments Year: 2019 Sinonasal inflammation in COPD: a systematic review Source: Eur Respir J 2013; 42: 1402-1411 Year: 2013 Alternative transcripts of cysteinyl leukotriene receptor 1 in patients with bronchial asthma Source: Annual Congress 2007 - Novel mediators of cellular pathology Year: 2007 Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective Source: Eur Respir J, 55 (5) 2001009; 10.1183/13993003.01009-2020 Year: 2020